Search bioRxivSearch

Biology subjects

Nickelsen, J.

Publications and source records attributed to Nickelsen, J..

2 recordsLinked to original sources

RNA recognition by the E2 subunit of the chloroplast pyruvate dehydrogenase from Chlamydomonas

The dihydrolipoamide acetyltransferase subunit (DLA2) of the chloroplast puruvate dehydrogenase complex (cpPDC) from the green alga Chlamydomonas reinhardtii has previously been shown to possess a moonlighting activity in chloroplast gene expression. Exclusively under mixotrophic growth conditions, DLA2 forms part of an RNP particle with the psbA mRNA that encodes the D1 protein of the photosystem II reaction center. Here, we report on the further characterization of DLA2s RNA-binding activity. Size-exclusion chromatography and Western analyses revealed that DLA2 is the only cpPDC subunit that shuttles between the metabolic cpPDC and the RNP complex. Microscale thermophoresis-based determination of RNA-binding affinities demonstrated that two DLA2 regions are crucial for RNA recognition, the peripheral E3-binding domain (E3BD) and the C-terminus of the catalytic domain. Specificity for the psbA RNA probe is conferred by the E3BD in vitro, as verified by competitive binding assays in the presence of an excess of the E3 (DLD2) of cpPDC. The data support a model in which an environmental trigger induces release of DLA2 from the cpPDC and its subsequent association with the psbA mRNA.

plant biology

Towards a biotechnological platform for the production of human growth factors in the green alga Chlamydomonas reinhardtii

The recent use of photosynthetic organisms such as Chlamydomonas reinhardtii in biomedical applications has demonstrated their potential for the treatment of acute and chronic tissue hypoxia. Moreover, transgenic microalgae have been suggested as an alternative in situ drug delivery system. In this study, we set out to identify the best available combination of strains and expression vectors to establish a robust platform for the expression of human pro-angiogenic growth factors, i.e. hVEGF-165, hPDGF-B, and hSDF-1, in biomedical settings. As a case study, combinations of two expression vectors (pOpt and pBC1) and two C. reinhardtii strains (UVM4 and UVM11) were compared with respect to hVEGF-165 transgene expression by determination of steady-state levels of transgenic transcripts as well as immunological detection of recombinant proteins produced and secreted by the generated strains. The results revealed the combination of the UVM11-strain with the pBC1-vector to be the most efficient one for high level hVEGF-165 production. To assess the robustness of this finding, the selected combination was used to create hPDGF-B and hSDF-1 transgenic strains for optimized recombinant protein expression. Furthermore, biological activity and functionality of algal-produced recombinant pro-angiogenic growth factors were assessed by receptor phosphorylation and in-vitro angiogenesis assays. The results obtained revealed a potentiating effect in the combinatorial application of transgenic strains expressing either of the three growth factors on endothelial cell tube formation ability, and thus support the idea of using transgenic algae expressing pro-angiogenic growth factors in wound healing approaches.

plant biology